Pyrogens are substances that cause fever post administering injection. Increase in body temperature and body ache are the prominent reactions caused due to injection of harmful pyrogens in the body. Pyrogen testing determines the presence of endotoxin substances. The global pyrogen testing market has been segmented on the basis of test type, application, end user, and regions.
The global pyrogen testing market was valued at US$ 538.8 Mn in 2015 and is estimated to be valued at US$ 594.4 Mn by 2016 end. The market is projected to expand at a CAGR of 11.0% during the forecast period in terms of value. Global pyrogen testing market value is expected to increase to US$ 1.37 billion by the end of 2024.
Growth of the global pyrogen testing market is mainly driven by growing number of pharmaceutical and biotechnology companies globally, increasing research and development investments and rising new drug approvals. In addition, other factors such as rising healthcare expenditure, increasing prevalence of chronic diseases and favorable government initiatives support the market growth. However, high barrier for new entrants is one of the prime factor that restrains the growth of the market over the forecast period. Increasing medical tourism in Asia Pacific and Latin American regions coupled with a growing healthcare industry in emerging economies define the future landscape of the pyrogen testing market.
Based on test type, the market has been segmented into recombinant factor C assay, limulus amebocyte lysate (LAL), monocyte activation assay (MAT), and rabbit pyrogen test. Limulus amebocyte lysate test is expected to dominate the global pyrogen testing market owing to rising preference for animal-free detection tests coupled with reliable detection of pyrogens support the dominance of this market segment. Rabbit pyrogen test is the oldest commercially available pyrogen testing method. However, rising preference for animal-free detection tests is a prominent factor that restricts uptake of this test type to some extent during the forecast period.
Based on application, the pyrogen testing market is segmented into injections, vaccines, tablets, medical devices and others. Injections and tablets segment are expected to dominate the global pyrogen testing application market over the forecast period.
Based on the end users, the market has been segmented into pharmaceutical industry, biotechnology industry, medical devices industry and others. Other segment includes cosmetic industry, food industry and others where pyrogen testing is utilized for the detection of pathogens. Pharmaceutical industry dominates the pyrogen testing market owing to increasing utilization of pyrogen testing in the pharmaceutical industry coupled with rising number of manufacturers and increasing healthcare awareness.
The global pyrogen testing market has been segmented into five major regions: North America, Latin America, Europe, Asia Pacific (APAC), and Middle East & Africa (MEA). In terms of value, North America is estimated to be the dominant market for global pyrogen testing market in 2016 owing to majority of the key players based in the region coupled with rising research and development activities and growing health care awareness. The North America pyrogen testing market is expected to expand at a CAGR of 10.8% over the forecast period. Limulus amebocyte lysate test (LAL) test type segment is expected to dominate the North America pyrogen testing market in 2016. The market segment is expected to register a CAGR of 11.3% over the forecast period. Asia Pacific and Latin America are estimated to be the fastest growing markets in terms of CAGR during the forecast period.
Key market players
Some of the key players having presence in the global pyrogen testing market are Charles River Laboratories International, Inc., Lonza Group, Ltd., Merck & Co., Associates of Cape Cod, Inc., Genscript, Wako Chemicals, and others. Companies operating in the global pyrogen testing market are focusing on expanding their product portfolio, owing to substantially high demand for pyrogen testing. Key market players are focusing on expanding their presence in Asian countries to meet the growing demand. Furthermore, increasing government initiatives for healthcare awareness in the region are also supporting growth of the market.
MRRSE offers custom market research services that help clients to get information on their business scenario required where syndicated solutions are not enough.Get A Free Custom Research Quote